Collagenous colitis is a chronic watery diarrhea disorder characterized by
a subepithelial collagen layer. The disease mainly affects middle-aged wome
n. The increasing number of publications indicates the growing interest on
this entity. The diagnosis predominantly depends on biopsies from the macro
scopically normal mucosa. The pronounced involvement of the proximal colon
underlines the necessity of a total colonoscopy. Immunhistochemistry shows
collagen type III. The etiology and pathogenesis of collagenous colitis is
less well understood. Recently published studies suggest a decreased collag
en desintegration rather than an accelerated collagen synthesis.
However, no standard treatment has been introduced by controlled clinical t
rials Symptomatic therapy with antidiarrhoica (e. g. loperamide, cholestyra
mine) or antiinflammatory drugs (e. g. aminosalicylates, systemically actin
g steroids) has been recommended. Moreover, the successful use a of the top
ically acting steroid budesonide indicates a good clinical:response and a s
mall number of side effects.